[ET Net News Agency, 14 September 2026] DUALITYBIO-B (09606) rose 10.2% to HK$185.9.
It hits an intra-day high of HK$186.1, breaking above the 20-D SMA of HK$185.25, and an intra-day low of HK$165.3. The total shares traded was 985,500, with a value of HK$175.79m. The active buy/sell ratio is 69:31, with net buying turnover of HK$63.46m. UBS accounts for greatest net responsive buying turnover of HK$4.28m, with volume weighted average price of HK$180.197. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$10.87m, with volume weighted average price of HK$178.66.
Basic Information| Nominal | 185.900 | % Chg | +10.20% |
| High | 186.100 | Low | 165.300 |
| Shares Tr | 985,500 | Turnover | 175.79m |
| 10-D SMA | 179.580 | %H.V | 54.796 |
| 20-D SMA | 185.250 | VWAP | 178.380 |
| 50-D SMA | 200.100 | RSI14 | 49.107 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 69:31, with net buying turnover of HK$63.46m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| DUALITYBIO-B (09606) | 185.90 | +10.20 |
| GENSCRIPT BIO (01548) | 33.92 | +4.82 |
| INNOVENT BIO (01801) | 96.60 | +3.26 |
| WUXI XDC (02268) | 75.85 | +5.20 |
| WUXI BIO (02269) | 49.36 | +5.02 |
| WUXI APPTEC (02359) | 198.80 | +5.30 |
| BEONE MEDICINES (06160) | 212.60 | +3.10 |
| SKB BIO (06990) | 484.00 | +4.04 |
| AKESO (09926) | 95.95 | +6.26 |
| INNOCARE (09969) | 15.64 | +15.51 |
(ed)
Nominal 
